medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

COVID-19: Risks of Re-emergence, Re-infection, and
Control Measures ‚Äì A Long Term Modeling Study
Subhas Kumar Ghosh1,a and Sachchit Ghosh2
1 Commonwealth

Bank of Australia, Sydney, New South Wales, 2000, Australia
University of Sydney, Camperdown, NSW 2006, Australia
a subhas.ghosh@cba.com.au
2 The

ABSTRACT
In this work we define a modified SEIR model that accounts for the spread of infection during the latent period, infections from
asymptomatic or pauci-symptomatic infected individuals, potential loss of acquired immunity, people‚Äôs increasing awareness of
social distancing and the use of vaccination as well as non-pharmaceutical interventions like social confinement. We estimate
model parameters in three different scenarios - in Italy, where there is a growing number of cases and re-emergence of the
epidemic, in India, where there are significant number of cases post confinement period and in Victoria, Australia where
a re-emergence has been controlled with severe social confinement program. Our result shows the benefit of long term
confinement of 50% or above population and extensive testing. With respect to loss of acquired immunity, our model suggests
higher impact for Italy. We also show that a reasonably effective vaccine with mass vaccination program can be successful in
significantly controlling the size of infected population. We show that for India, a reduction in contact rate by 50% compared to
a reduction of 10% in the current stage can reduce death from 0.0268% to 0.0141% of population. Similarly, for Italy we show
that reducing contact rate by half can reduce a potential peak infection of 15% population to less than 1.5% of population, and
potential deaths from 0.48% to 0.04%. With respect to vaccination, we show that even a 75% efficient vaccine administered to
50% population can reduce the peak number of infected population by nearly 50% in Italy. Similarly, for India, a 0.056% of
population would die without vaccination, while 93.75% efficient vaccine given to 30% population would bring this down to
0.036% of population, and 93.75% efficient vaccine given to 70% population would bring this down to 0.034%.

Introduction
In December 2019, an outbreak occurred in Wuhan, China involving a zoonotic coronavirus, similar to the SARS coronavirus
and MERS coronavirus1 . Subsequently, the virus has been named Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2), and the disease caused by the virus has been named the coronavirus disease 2019 (COVID-19). Since then the ongoing
pandemic has infected more than 30 million people and has caused more than 900 thousand deaths worldwide.
Patients with SARS-CoV-2 infections have mild to severe respiratory illness with symptoms such as fever, cough and
shortness of breath. For majority of the patients, these symptoms appear 2‚Äì14 days after exposure, and for majority the
symptoms are not life threatening. However, it has been reported that there are patients who are diagnosed by a positive
RT‚ÄìPCR test but are either asymptomatic or minimally symptomatic2‚Äì6 . There are reasonable evidence to consider that such
asymptomatic or minimally symptomatic individuals have longer duration of viral shedding than the symptomatic individuals
and can spread the virus to susceptible group6 . Hence, it is possible that the spread of SARS-CoV-2 is much higher and such
undetermined transmission has been playing an important role in sustaining the community spread.
Mathematical Modeling plays an important role in understanding the trajectory of epidemic and design effective control
measures under set of assumptions7‚Äì9 . Here, we propose a new deterministic compartmental model for the COVID-19 epidemic
that extends the classical SEIR (susceptible, exposed, infectious, recovered) model. We define the model and its parameters to
address three different scenarios - in Italy, where there is a growing number of cases and re-emergence of the epidemic, in India,
where there are significant number of cases post confinement period and in Victoria, Australia where a re-emergence has been
controlled with severe social confinement program. In our model we also consider long term scenarios including re-emergence,
re-infection, and control measures like mass vaccination program. Other than simulating these scenarios, another important
distinction of our model is that we use parametric functions for contact rate, testing and vaccination.
We use a deterministic compartmental model that is an extension of the SEIR model8, 10 in which we include current
experience with SARS-CoV-2. We partition the total population into susceptible individuals (S(t)), exposed individuals
(E(t)), Asymptomatic, undetected and infected individuals (A(t)), Symptomatic, undetected, and infected individuals (I(t)),
Asymptomatic, diagnosed and infected individuals (Q(t)), Symptomatic, diagnosed, and infected individuals (H(t)), individuals
with acute symptoms and in critical care (C(t)), and recovered (R(t)) and deceased (D(t)), see Figure 1.
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Œµ(t)

A(t)
(1 ‚àí Œ±)œÉ
S(t)

Œ≤ (t)

ŒΩ symptom

Q(t)

œï symptom

onset

E(t)

contagion

detection

Œ±œÉ
Œ∏

I(t)

H(t)

detection

Œ∑
¬µ
Œ≥

œÑ acute symptom

recovery

œà
R(t)

Œ∂

Œª

acute symptom

C(t)
Œ¥

death

D(t)
Figure 1. The model consists of following compartments: susceptible S(t)‚Äû exposed E(t), asymptomatic A(t), symptomatic
I(t), quarantined Q(t), isolated H(t), deceased (D(t) and recovered R(t) individuals in a population of
N(t) = S(t) + E(t) + A(t) + I(t) + Q(t) + H(t) + R(t) + D(t) individuals.
The transmission dynamics of COVID-19 in the basic model is given by the following deterministic system of nonlinear
differential equations (1)-(10):
S
dE
= Œ≤ (t) (I + Œ∫A + œâQ + œÅH) ‚àí œÉ E,
dt
N

(1)

dI
= Œ±œÉ E + ŒΩA ‚àí (Œ∑ + Œ∏ + Œª ) I,
dt

(2)

dA
= (1 ‚àí Œ±) œÉ E ‚àí (Œµ(t) + ŒΩ + Œ≥) A,
dt

(3)

dQ
= Œµ(t)A ‚àí (œï + ¬µ) Q,
dt

(4)

dH
= Œ∏ I + œïQ ‚àí (œÑ + œà) H,
dt

(5)

dC
= œÑH + Œª I ‚àí (Œ¥ + Œ∂ )C,
dt

(6)

dD
= Œ¥C,
dt

(7)

dR
= (Œ∑I + Œ≥A + ¬µQ + œàH + Œ∂C) ,
dt

(8)
2/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

dS
S
= ‚àíŒ≤ (t) (I + Œ∫A + œâQ + œÅH) ,
dt
N

(9)

where,
N(t) = S(t) + E(t) + A(t) + I(t) + Q(t) + H(t) + R(t) + D(t),

(10)

is the total population.
Susceptible individuals: S(t)

In our model, the susceptible individuals gets exposed to infection, and move to exposed group E(t), from coming in contact
with an infected individual, who may be symptomatic, asymptomatic, quarantined, or isolated. Œ≤ (t) is the baseline infectious
contact rate, which can vary with time or assumed constant for the analysis of our baseline model. We assume that a person who
is infected with symptom, and is not isolated, has the basic transmission coefficient of Œ≤ (t), that is changing over time. Based
on11, 12 , we define Œ≤ (t) to have a value Œ≤0 till time t0 and then as a decreasing function with respect to time t, to reaching Œ≤min .
(
Œ≤0
t < t0
Œ≤ (t) =
(11)
‚àír(t‚àít
)
0
Œ≤min + (Œ≤0 ‚àí Œ≤min ) e
t ‚â• t0
We would like to note that in certain countries, stringency measures were in place at an earlier stages of the epidemic and was
relaxed over time leading to a higher contact rate. Under such scenario, we use an increasing function for Œ≤ (t) after an initial
phase of reaching or nearing Œ≤min as
Ô£±
Ô£¥
t < t0
Ô£≤Œ≤0
‚àír(t‚àít
)
0
Œ≤ (t) = Œ≤min + (Œ≤0 ‚àí Œ≤min ) e
(12)
t0 ‚â§ t < t1
Ô£¥
Ô£≥
Œ≤new ‚àí (Œ≤new ‚àí Œ≤min )e‚àíu(t‚àít1 ) t ‚â• t1
We assume that the asymptomatic individuals infect with a lower contact rate (Œ∫ < 1) than the symptomatic individuals. Once
someone symptomatic is diagnosed, they can only infect healthcare workers and this lower contact rate is captured by the
parameter (œÅ < 1). Similarly, quarantined individuals have much lower contact rate of (œâ < 1). Overall rate of change for the
susceptible population is thus defined by equation (9).
Exposed individuals: E(t)

Individuals in compartment E, are exposed to the virus, and are not contagious during a period of latent time. An individual in
E becomes infectious, and moves to compartment A as asymptomatic or to I as symptomatic. We assume that œÉ is the transition
rate from exposed to infectious, and a fraction Œ± of them show symptoms. Overall rate of change for the exposed population is
thus defined by equation (1).
Symptomatic individuals: I(t)

Symptomatic individuals can get diagnosed (Œ∏ ) and be isolated, or show acute symptoms and be hospitalized (Œª ), or can
recover at the rate Œ∑. It has been observed that Œ∑ ‚â• Œ≥, where symptomatic individuals recover at faster rate than asymptomatic
individuals, and asymptomatic individuals have longer duration of viral shedding6 . Overall rate of change is given by equation
(2).
Asymptomatic individuals: A(t)

Asymptomatic individuals can eventually show symptoms and move to I at rate ŒΩ or can have a positive diagnosis and move to
quarantine. We model testing of asymptomatic population as a function of time as the community testing process ramps up.
Testing rate has been captured as Œµ(t). Finally, they can recover at the rate Œ≥. Overall rate of change is given by equation (3). A
note on testing rate is in order. We model it as following:
(
Œµ0
t < t2
Œµ(t) =
(13)
‚àís(t‚àít
)
2
Œµmax ‚àí (Œµmax ‚àí Œµ0 )e
t > t2
Here, we set the testing rate as an increasing function of time, because of the increasing production of detection kits and the
improvement of detection techniques. Where, 1/Œµ0 can be thought of waiting time for an individual to get tested in the start of an
outbreak and 1/Œµmax is the reduced waiting time at a later point during the epidemic. In other words, limt‚Üí‚àû Œµ(t) = Œµmax ‚â• Œµ0 .
3/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Quarantined individuals: Q(t)

Quarantined individuals are asymptomatic population after diagnosis and they have very low contact rate (œâ < 1). This is
mostly by infecting the other family members or by breach of protocol. They however, may develop symptoms and move to H
or recover. Overall rate of change is given by equation (4).
Isolated individuals: H(t)

Isolated individuals are showing symptoms and has been either home isolated or has been hospitalized. They can pass the
infection to a limited number of health care professional or caregiver (œÅ). They can become critical and require treatments in
intensive care (œÑ), and a large number of them recover (œà). Overall rate of change is given by equation (5).
Critical, Recovered and Deceased individuals: C(t), R(t), D(t)

These counters collect information on population that are critical, recovered or have deceased. Overall rate of change is given
by equations (6) - (8). We assume that in the base model, recovered individuals possess lasting immunity against SARS-CoV-2
over the period of simulation, however, we extend the model to consider the possibility of re-infection in later section of this
paper.

Results
Italy
For the COVID-19 epidemic in Italy, we estimate the model parameters based on data from 24th February 2020 (day 1) to
27th August 2020 (day 186) and show the effects of social confinement that is in effect since 9 March 2020, in controlling the
spread of the epidemic, and subsequently easing the restriction from 4th May 2020 has again increased contact rate leading to
re-emergence. We also model possible longer-term scenarios illustrating the effects of different countermeasures, including
social distancing, population-wide testing, vaccination to contain SARS-CoV-2, as well as possible effects of re-infection and
loss of immunity.
Model simulation compared to real data is shown in Figure 2. We have estimated R0 according to equation (23). In our
estimate R0 = 4.09 in the beginning and then reduces to 0.779 after 45 days, and to 0.18 after 90 days. Subsequently, after 110
days it starts increasing and reaches a value 1.67 on day 186.
In Figure 3, we show both short term and long term evolution after fitting the model to data. Result shows that without any
control measure in long term a significant portion of population getting infected. Hence, we consider the effect of continued
social distancing, awareness and confinement measures by sensitivity analysis of contact rate parameter Œ≤ (t). We consider
reducing Œ≤ (t) by 50%, 40%, 30%, 20% and 10% from current contact rate. Figure 4, indicates that reducing contact rate by half
can reduce a potential peak infection of 15% population to less than 1.5% of population, and potential deaths from 0.48% to
0.04%.
Subsequently, we also consider the effects of testing and rate of detection of latent cases Œµ(t). We consider changing
the current testing rate by 2, 4, 6, 8 and 10 times the current rate. Figure 5, the simulation of the model after fitting current
data indicates that an increased testing rate by 10 times will reduce potential peak infection rate from 18% of population to
14%, deaths from 0.48% to 0.42%. Our model confirms that extensive testing campaigns can reduce the infection peak (as
the diagnosed population enters quarantine and is therefore less likely to affect the susceptible population) and help end the
epidemic more quickly. However, it can be observed that sensitivity of contact rate is much more significant than testing. This
is also due to that fact that in our model we have considered Œµ as a parameter that impacts how asymptomatic cases are moved
to quarantine, while infection from asymptomatic cases are lower compared to symptomatic cases.
As described by extended model in equation - (32) and (33), we consider the possibility of losing acquired immunity over
time and having a reinfection, we use parameter œá(t) to capture this. In our simulation we consider that œá varies from 1/250 to
1/50. This can be thought as number of days to lose immunity and hence corresponds to 250 days to 50 days. As expected,
the simulation shows that if loss of immunity occurs within 3 months, there is a significant chance of subsequent waves of
epidemic.
Finally, we simulate mass vaccination scenarios (see Figure 7 and Figure 8) according to equation (35), (36), (37), (38) and
(34). We assume that vaccine is available after 90 days from 27th August 2020. œÜ is varied from 1.0 (No vaccination), 0.5 (50%
efficient), 0.25 (75% efficient), 0.125(87.5% efficient), and 0.0625 (93.75% efficient) and Œæmax = 0.5 and Œæmax = 0.9. It can be
concluded that even a 75% efficient vaccine can be significantly effective in reducing the impact.
India
India had one of the most strict stay home order across the country in first phase of the lock-down between 25 March 2020
‚Äì 14 April 2020 (21 days), where an entire population of 1.3 billion people was put under restricted movement. Overall the
lock-down had multiple phases, second phase was from 15th of April 2020 to 3rd of May 2020, and third phase was 4th of May
to 17th of May, 2020.
4/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

b
Currently Infected: Model vs. Data

0.004

0.003

0.002

0.001

0.000

0

25

50

75

100
Time (days)

125

150

0.003

0.002

0.001

0

25

50

75

100
Time (days)

125

150

175

150

175

150

175

d
Infected, Life-Threatening Symptoms: Model vs. Data

0.004

0.003

0.002

0.001

0.000

0

25

50

75

100
Time (days)

125

150

Deaths: Model vs. Data

0.005
Cases (fraction of the population)

0.005
Cases (fraction of the population)

0.004

0.000

175

c

0.004

0.003

0.002

0.001

0.000

175

e

0

25

50

75

100
Time (days)

125

f
Infected, No Symptoms: Model vs. Data

0.004

0.003

0.002

0.001

0.000

0

25

50

75

100
Time (days)

125

150

Infected, Symptoms: Model vs. Data

0.005
Cases (fraction of the population)

0.005
Cases (fraction of the population)

Recovered: Model vs. Data

0.005
Cases (fraction of the population)

Cases (fraction of the population)

0.005

175

0.004

0.003

0.002

0.001

0.000

0

25

50

75

100
Time (days)

125

Figure 2. Model simulation compared to real data (Italy) - Comparison between the official data (histogram) and the results
with our model. Description
of panels: (a): Number of currently active cases, (Q(t) + H(t) +C(t)), (b): number of reported
R
recovered individuals. 0t (¬µQ(s) + œàH(s) + Œ∂C(s)) ds, (c): number of reported infected with life-threatening symptoms,
admitted to ICU, C(t), (d): Number of deceased individuals D(t), (e): number of reported infected with no (or mild)
symptoms, who are quarantined at home. Q(t) , (f): number of reported infected with symptoms, who are hospitalized. H(t)

We use data from Johns Hopkins University Center for Systems Science and Engineering (JHU CSSE). We use data from
2nd March 2020 (Day 1) to 16th September 2020 (Day 198). Figure 9 compares the fitted model with actual data. Based on our
estimate, initial value of R0 was 1.762, which reduces to 1.68 after a month when lockdown as in place. At the end of lockdown
phases it is about 1.5, and finally after 194 days it reaches 1.03. These values are comparable with findings in13, 14 .
We have simulated the long term evolution of the epidemic for India after estimating the parameters as shown in Figure 10.
Simulation suggests that peak in India will be reached around 275 days from 2nd March 2020 with about 2.6% population
5/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

b
Short-term evolution: actual vs diagnosed cases of infection
Recovered
Deaths
Diagnosed recovered
Cumulative infected
Current total infected
Current total infected: Data

0.004

0.002

0.001

0.4

0.3

0.2

0.1

0

25

50

75

100
125
Time (days)

150

175

0.0

200

c

0

100

200

300
400
Time (days)

500

600

700

d
Short-term evolution: Infected sub-population

0.005

0.004

0.003

0.002

0.001

0.000

0

25

50

75

100
125
Time (days)

150

175

Long-term evolution: Infected sub-population

0.25

Symptomatic, Undected
Symptomatic, Diagnosed
Asymptomatic, Undected
Isolated
Critical

Cases (fraction of the population)

Cases (fraction of the population)

Recovered
Deaths
Diagnosed recovered
Cumulative infected
Current total infected
Current total infected: Data

0.5

0.003

0.000

Long-term evolution: actual vs diagnosed cases of infection

0.6

Cases (fraction of the population)

Cases (fraction of the population)

0.005

200

Symptomatic, Undected
Symptomatic, Diagnosed
Asymptomatic, Undected
Isolated
Critical

0.20

0.15

0.10

0.05

0.00

0

100

200

300
400
Time (days)

500

600

700

Figure 3. Model simulation compared to real data (Italy) - Epidemic evolution predicted by the model based on the available
data. Description of panels: (a, c): The short-term epidemic evolution obtained by reproducing the data trend with the model,
(b, d): Long term epidemic evolution over 700 days. Plots refers to all cases of infection, both diagnosed and non-diagnosed,
predicted by the model, although non-diagnosed cases are of course not counted in the data. Note that not all panels are in the
same scale.

getting infected.
Simulation studies on impact of reducing contact rate and testing is captured in Figure 11 and Figure 12 respectively. From
the simulation we can observe that the sensitivity to contact rate is higher compared to increased testing. A reduction in contact
rate by 50% compared to a reduction of 10% can reduce death from 0.0268% to 0.0141% of population.
Figure 13 show the simulation study loss of acquired immunity for scenario in India. We note that this model is not very
sensitive to œá(t). This is due to the size of the population and current state of the epidemic in India - reinfection within 2 months
changes total number of infected population from 2.66% to 2.98%, while reinfection after 250 days changes this to 2.768%.
Simulation studies for vaccination is presented in Figure 14 and Figure 15. We assume that the vaccine is available from 90
days after 16th September 2020. Simulation suggests that a 0.056% of population would die without vaccination, while 93.75%
efficient vaccine given to 30% population would bring this down to 0.036% of population, and 93.75% efficient vaccine given
to 70% population would bring this down to 0.034%.
6/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

b

0.175
0.150
0.125
0.100
0.075
0.050
0.025
0

200

400
Time (days)

0.25

d
Sensitivity w. r. t. Œ≤(t): Deaths
50%
40%
30%
20%
10%

0.10

0.05

0

200

0.25

400
Time (days)

0.20

0.15

0.10

0.05

0

200

400
Time (days)

600

0.15

0.10

0.05

0

200

400
Time (days)

600

f

0.25

50%
40%
30%
20%
10%

0.20

0.15

0.10

0.05

0.00

50%
40%
30%
20%
10%

0.20

0.00

600

Sensitivity w. r. t. Œ≤(t): Cumulative Infected
Cases (fraction of the population)

Cases (fraction of the population)

0.15

Sensitivity w. r. t. Œ≤(t): Cumulative Recovered

e

0.25

0.00

0.20

0.00

600

50%
40%
30%
20%
10%

0

200

400
Time (days)

600

Sensitivity w. r. t. Œ≤(t): Critical

0.005
Cases (fraction of the population)

0.000

Sensitivity w. r. t. Œ≤(t): Detected and Recovered
Cases (fraction of the population)

Cases (fraction of the population)

50%
40%
30%
20%
10%
Actual Data

Cases (fraction of the population)

Sensitivity w. r. t. Œ≤(t): Currently infected

0.200

c

50%
40%
30%
20%
10%

0.004

0.003

0.002

0.001

0.000

0

200

400
Time (days)

600

Figure 4. Sensitivity of Œ≤ (t) with 50%, 40%, 30%, 20% and 10% reduction from current contact rate (Italy). Note that not all
panels are in the same scale.
Victoria, Australia
For Victoria, Australia we use data from 27 February, 2020 (day 1) to 9 September, 2020 (day 195). Consistent with other
places Victoria had initial outbreak during March and April 2020 - which was effectively controlled. Control measures were
relaxed during June 2020 to revive economic activities. Based on our estimate R0 in Victoria was 2.72 in the beginning of
July. A stricter confinement was placed in selected localities on 1 July 2020, which was extended to the whole of metropolitan
Melbourne and Mitchell Shire on 8 July. Estimated by our model, R0 was 2.86 at that time. However, the restriction was
effective to bring down R0 to 1.13 by 30, July, 2020. We note that our findings are similar to15 . In our estimate, current R0 is
well below 1.

Methods
Baseline mathematical models
Baseline epidemiological parameters

In this section we describe the estimated values of various parameters based on the current literature. It has been noted in the
literature that the clinical course of the disease is typically quite long. Average total duration of illness has been estimated to
be three weeks in16 . Parameter Œ≤0 is strongly dependent on the population behavior. We select a default value that has been
estimated in17 for pre-lockdown period. Baseline values for various parameters are listed in the Table - 1.
The basic reproduction number for baseline model

The basic reproduction number is calculated for the special case when we have Œ≤ (t) = Œ≤0 , Œµ(t) = Œµ0 . In following we explore
the local stability of the disease-free equilibrium (DFE) using the next generation operator method23, 24 . Following24 , we define
the system of equations (1)-(10), in more compact form as:
XÃá = f (X) = F (X) ‚àí V (X),

(14)
7/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

b

0.15

0.10

0.05

0.00

0

200

400
Time (days)

2
4
6
8
10

0.8

0.6

0.4

0.2

0.0

600

d

0

200

1.0

400
Time (days)

2
4
6
8
10

0.20

0.15

0.10

0.05

0.00

0

200

400
Time (days)

600

1.0

2
4
6
8
10

0.8

0.6

0.4

0.2

0.0

0.6

0.4

0.2

0

200

400
Time (days)

600

f

Sensitivity w. r. t. (t): Cumulative Infected
Cases (fraction of the population)

Sensitivity w. r. t. (t): Deaths

2
4
6
8
10

0.8

0.0

600

e

0.25
Cases (fraction of the population)

Sensitivity w. r. t. (t): Cumulative Recovered

1.0

Cases (fraction of the population)

0.20

Sensitivity w. r. t. (t): Detected and Recovered

0

200

400
Time (days)

600

Sensitivity w. r. t. (t): Critical

0.025
Cases (fraction of the population)

Cases (fraction of the population)

2
4
6
8
10

Cases (fraction of the population)

Sensitivity w. r. t. (t): Currently infected

0.25

c

2
4
6
8
10

0.020

0.015

0.010

0.005

0.000

0

200

400
Time (days)

600

Figure 5. Sensitivity of Œµ(t) with changed rate of testing by 2, 4, 6, 8 and 10 times the current rate (Italy). Note that not all
panels are in the same scale.

where, X = (E, I, A, Q, H,C, D, R, S)t , and F (X) containing rate of appearance of new infections defined as:

Ô£´
Ô£∂
Œ≤0 (I + Œ∫A + œâQ + œÅH) NS
Ô£¨
Ô£∑
0
Ô£¨
Ô£∑
Ô£¨
Ô£∑
0
Ô£¨
Ô£∑
Ô£¨
Ô£∑
0
Ô£¨
Ô£∑
Ô£¨
Ô£∑,
F (X) = Ô£¨
0
Ô£∑
Ô£∑
Ô£¨
0
Ô£¨
Ô£∑
Ô£¨
Ô£∑
0
Ô£∑
Ô£¨
Ô£≠
Ô£∏
0
0

(15)

8/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

b

0.20
0.15
0.10
0.05
0.00

0

200

400
Time (days)

250 days
200 days
150 days
100 days
50 days

0.8

0.6

0.4

0.2

0.0

600

d

0

200

400
Time (days)

1.0

250 days
200 days
150 days
100 days
50 days

0.20

0.15

0.10

0.05

0.00

0

200

400
Time (days)

600

0.4

0.2

0

200

400
Time (days)

600

Sensitivity w. r. t. œá: Currently Critical

1.0

250 days
200 days
150 days
100 days
50 days

0.8

0.6

0.4

0.2

0.0

0.6

f

Sensitivity w. r. t. œá: Cumulative Infected
Cases (fraction of the population)

Sensitivity w. r. t. œá: Cumulative Deaths

250 days
200 days
150 days
100 days
50 days

0.8

0.0

600

e

0.25
Cases (fraction of the population)

Sensitivity w. r. t. œá: Cumulative Recovered

1.0

Cases (fraction of the population)

0.25

Sensitivity w. r. t. œá: Cumulative Detected and Recovered

0

200

400
Time (days)

0.008
Cases (fraction of the population)

Cases (fraction of the population)

250 days
200 days
150 days
100 days
50 days

Cases (fraction of the population)

Sensitivity w. r. t. œá: Currently infected

0.30

c

600

250 days
200 days
150 days
100 days
50 days

0.007
0.006
0.005
0.004
0.003
0.002
0.001
0.000

0

200

400
Time (days)

600

Figure 6. Sensitivity of œá(t) with loss of acquired immunity over time by 250, 200, 150, 100 and 50 days (Italy). Note that not
all panels are in the same scale.
and, V (X) capturing the movement between the compartments, with V ‚àí (X) as the rate of outward transfer, and V + (X) as the
rate of inward transfer for each compartment, we have,
V (X) = V ‚àí (X) ‚àí V + (X)
Ô£´
Ô£∂ Ô£´
Ô£∂
œÉE
0
Ô£¨
Ô£∑ Ô£¨
Ô£∑
(Œ∑ + Œ∏ + Œª ) I
Œ±œÉ E + ŒΩA
Ô£¨
Ô£∑ Ô£¨
Ô£∑
Ô£¨
Ô£∑ Ô£¨
Ô£∑
(Œµ
+
ŒΩ
+
Œ≥)
A
(1
‚àí
Œ±)
œÉ
E
0
Ô£¨
Ô£∑ Ô£¨
Ô£∑
Ô£¨
Ô£∑ Ô£¨
Ô£∑
(œï
+
¬µ)
Q
Œµ
A
0
Ô£¨
Ô£∑ Ô£¨
Ô£∑
Ô£∑‚àíÔ£¨
Ô£∑
(œÑ
+
œà)
H
Œ∏
I
+
œïQ
=Ô£¨
Ô£¨
Ô£∑ Ô£¨
Ô£∑
Ô£¨
Ô£∑ Ô£¨
Ô£∑
(Œ¥
+
Œ∂
)C
œÑH
+
Œª
I
Ô£¨
Ô£∑ Ô£¨
Ô£∑
Ô£¨
Ô£∑ Ô£¨
Ô£∑
0
Œ¥C
Ô£¨
Ô£∑ Ô£¨
Ô£∑
Ô£≠
Ô£∏ Ô£≠(Œ∑I + Œ≥A + ¬µQ + œàH + Œ∂C)Ô£∏
0
0
Œ≤0 (I + Œ∫A + œâQ + œÅH) NS
Ô£∂
œÉE
Ô£¨ (Œ∑ + Œ∏ + Œª ) I ‚àí Œ±œÉ E ‚àí ŒΩA Ô£∑
Ô£¨
Ô£∑
Ô£¨ (Œµ0 + ŒΩ + Œ≥) A ‚àí (1 ‚àí Œ±) œÉ E Ô£∑
Ô£¨
Ô£∑
Ô£∑
Ô£¨
(œï + ¬µ) Q ‚àí Œµ0 A
Ô£¨
Ô£∑
Ô£¨
Ô£∑
(œÑ + œà) H ‚àí Œ∏ I ‚àí œïQ
V (X) = Ô£¨
Ô£∑
Ô£∑
Ô£¨
(Œ¥ + Œ∂ )C ‚àí œÑH ‚àí Œª I
Ô£¨
Ô£∑
Ô£∑
Ô£¨
‚àíŒ¥C
Ô£∑
Ô£¨
Ô£≠‚àí (Œ∑I + Œ≥A + ¬µQ + œàH + Œ∂C)Ô£∏
Œ≤0 (I + Œ∫A + œâQ + œÅH) NS

(16)

Ô£´

(17)

9/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

b

0.15

0.10

0.05

0.00

0

200

400
Time (days)

0.6

0.4

0.2

0

200

400
Time (days)

1.0

Sensitivity w. r. t. œÜ: Cumulative Deaths

0.07
0.06
0.05
0.04
0.03
0.02
0.01
0

200

400
Time (days)

600

0.4

0.2

0

200

400
Time (days)

600

Sensitivity w. r. t. œÜ: Currently Critical

1.0

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

0.8

0.6

0.4

0.2

0.0

0.6

f

Sensitivity w. r. t. œÜ: Cumulative Infected
Cases (fraction of the population)

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

0.8

0.0

600

e

0.08
Cases (fraction of the population)

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

0.8

0.0

600

d

0.00

Sensitivity w. r. t. œÜ: Cumulative Recovered

1.0

Cases (fraction of the population)

0.20

Sensitivity w. r. t. œÜ: Cumulative Detected and Recovered

0

200

400
Time (days)

0.008
Cases (fraction of the population)

Cases (fraction of the population)

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

Cases (fraction of the population)

Sensitivity w. r. t. œÜ: Currently infected

0.25

c

600

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

0.007
0.006
0.005
0.004
0.003
0.002
0.001
0.000

0

200

400
Time (days)

600

Figure 7. Sensitivity of vaccine efficiency parameter (1 ‚àí œÜ ), where œÜ = 0 represents vaccine that offers 100% protection
against infection, and Œæmax = 0.5, i.e. maximum of 50% population is administered with vaccine. œÜ is varied from 1.0 (No
vaccination), 0.5 (50% efficient), 0.25 (75% efficient), 0.125(87.5% efficient), and 0.0625 (93.75% efficient) (Italy)

We also define Xs , as the set of all possible disease free states. In order to directly apply the results in24 , following shall hold
for equation XÃá = f (x) = F (X) ‚àí V (X):
1. Functions F (X), V ‚àí (X) and V + (X), are all non-negative, when X > 0.

2. If X ‚àà Xs , then V ‚àí (x) = F (x) = V + (x) = 0 for x ‚àà {E, I, A, Q, H,C, D, R}.
3. Let D f (X0 ) be the Jacobian matrix evaluated at DFE X0 , and defined as the partial derivative [‚àÇ f /‚àÇ x] for x ‚àà
{E, I, A, Q, H,C, D, R, S}. If F (X) = 0, then all eigenvalues of D f (X0 ) has negative real parts.
We note that each function represents a directed transfer of individuals, and they are all non-negative. (1) and (2), can be
observed from the equations (15) and (17). For (3), setting F (X) = 0, we consider linearized system XÃá = ‚àíDV (X0 )(X ‚àí X0 ),
near DFE. From equation (20) we observe that eigenvalues corresponding to D f (X0 ) has zero eigenvalues of multiplicity 3
with associated eigenvectors in the directions of D, R, S. The results in24 still holds for our system for stability in the directions
of the susceptible and recovered compartment (note that )as D is a counting compartment), this however, has no consequence in
the meaning of the threshold R0 . In fact this technicality can be resolved by adding natural birth and death rates proportional to
the compartments S and R that is arbitrarily small and positive. Let X0 ‚àà Xs be a DFE. Then X0 = (0, 0, 0, 0, 0, 0, 0, 0, S0 ), and
10/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

b

0.20

0.15

0.10

0.05

0.00

0

200

400
Time (days)

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

0.8

0.6

0.4

0.2

0.0

600

d

0

200

400
Time (days)

1.0

Sensitivity w. r. t. œÜ: Cumulative Deaths

0.05
0.04
0.03
0.02
0.01
0.00

0

200

400
Time (days)

0.8

0.6

0.4

0.2

0.0

600

0.2

0

200

400
Time (days)

600

0.008

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

Cases (fraction of the population)

0.06

0.4

Sensitivity w. r. t. œÜ: Currently Critical

1.0

Cases (fraction of the population)

0.07

0.6

f

Sensitivity w. r. t. œÜ: Cumulative Infected

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

0.8

0.0

600

e

0.08
Cases (fraction of the population)

Sensitivity w. r. t. œÜ: Cumulative Recovered

1.0

Cases (fraction of the population)

Cases (fraction of the population)

Sensitivity w. r. t. œÜ: Cumulative Detected and Recovered

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

Cases (fraction of the population)

Sensitivity w. r. t. œÜ: Currently infected

0.25

c

0

200

400
Time (days)

0.006
0.005
0.004
0.003
0.002
0.001
0.000

600

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

0.007

0

200

400
Time (days)

600

Figure 8. Sensitivity of vaccine efficiency parameter (1 ‚àí œÜ ), where œÜ = 0 represents vaccine that offers 100% protection
against infection, and Œæmax = 0.9. œÜ is varied from 1.0 (No vaccination), 0.5 (50% efficient), 0.25 (75% efficient), 0.125(87.5%
efficient), and 0.0625 (93.75% efficient) (Italy)
a
Currently Infected: Model vs. Data

0.0020

0.0015

0.0010

0.0005

0.0025

0.0020

0.0015

0.0010

0.0005

50

100
150
Time (days)

0.0000

Deaths: Model vs. Data

0.0030

0.0025
Cases (fraction of the population)

Cases (fraction of the population)

Recovered: Model vs. Data

0.0030

0.0025

0.0000

c

Cases (fraction of the population)

0.0030

b

0.0020

0.0015

0.0010

0.0005

50

100
150
Time (days)

0.0000

50

100
150
Time (days)

Figure 9. Model simulation compared to real data (India) - Comparison between the official data (histogram) and the results
with our model. Description
of panels: (a): Number of currently active cases, (Q(t) + H(t) +C(t)), (b): number of reported
R
recovered individuals. 0t (¬µQ(s) + œàH(s) + Œ∂C(s)) ds, (c): Number of deceased individuals D(t)

11/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

b
Short-term evolution: actual vs diagnosed cases of infection

0.00020

0.00015

0.00010

0.00005

0.00000

0

10

20

30

40
50
Time (days)

60

70

80

Recovered
Deaths
Diagnosed recovered
Cumulative infected
Current total infected

0.04

0.03

0.02

0.01

0.00

90

c

0

100

200

300
400
Time (days)

500

600

700

d
Short-term evolution: Infected sub-population

0.00025

0.00020

0.00015

0.00010

0.00005

0.00000

0

10

20

30

40
50
Time (days)

60

70

Long-term evolution: Infected sub-population

0.0010

Symptomatic, Undected
Symptomatic, Diagnosed
Asymptomatic, Undected
Isolated
Critical

Cases (fraction of the population)

Cases (fraction of the population)

Long-term evolution: actual vs diagnosed cases of infection

0.05

Recovered
Deaths
Diagnosed recovered
Cumulative infected
Current total infected

Cases (fraction of the population)

Cases (fraction of the population)

0.00025

80

90

Symptomatic, Undected
Symptomatic, Diagnosed
Asymptomatic, Undected
Isolated
Critical

0.0008

0.0006

0.0004

0.0002

0.0000

0

100

200

300
400
Time (days)

500

600

700

Figure 10. Model simulation compared to real data (India) - Epidemic evolution predicted by the model based on the
available data. Description of panels: (a, c): The short-term epidemic evolution obtained by reproducing the data trend with the
model for 90 days, (b, d): Long term epidemic evolution over 700 days. Plots refers to all cases of infection, both diagnosed
and non-diagnosed, predicted by the model, although non-diagnosed cases are of course not counted in the data. Note that not
all panels are in the same scale.

with S0 /N0 = 1 we have,

Ô£´
0 Œ≤0
Ô£¨0 0
Ô£¨
Ô£¨0 0
Ô£¨
Ô£¨0 0
Ô£¨
DF (X0 ) = Ô£¨
Ô£¨0 0
Ô£¨0 0
Ô£¨
Ô£¨0 0
Ô£¨
Ô£≠0 0
0 0

Œ∫Œ≤0
0
0
0
0
0
0
0
0

œâŒ≤0
0
0
0
0
0
0
0
0

œÅŒ≤0
0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0
0

Ô£∂
0
0Ô£∑
Ô£∑
0Ô£∑
Ô£∑

0Ô£∑
Ô£∑
F
Ô£∑
0Ô£∑ =
0
0Ô£∑
Ô£∑
0Ô£∑
Ô£∑
0Ô£∏
0


0
0

(18)

12/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

b

0.0007
0.0006
0.0005
0.0004
0.0003
0.0002
0.0001
0

200

400
Time (days)

0.006

0.004

50%
40%
30%
20%
10%

0.002

0

200

400
Time (days)

Sensitivity w. r. t. Œ≤(t): Deaths

0.025

0.0006

Cases (fraction of the population)

0.0008

0.0004

0.0002

0

200

400
Time (days)

600

50%
40%
30%
20%
10%

0.020

0.015

0.010

0.005

0.000

0.015

0.010

0.005

0

200

400
Time (days)

600

f

Sensitivity w. r. t. Œ≤(t): Cumulative Infected

50%
40%
30%
20%
10%

50%
40%
30%
20%
10%

0.020

0.000

600

e

0.0010
Cases (fraction of the population)

0.025

0.008

0.000

600

d

0.0000

Sensitivity w. r. t. Œ≤(t): Cumulative Recovered

0.010

0

200

400
Time (days)

600

Sensitivity w. r. t. Œ≤(t): Critical

0.000200
Cases (fraction of the population)

0.0000

Sensitivity w. r. t. Œ≤(t): Detected and Recovered
Cases (fraction of the population)

Cases (fraction of the population)

50%
40%
30%
20%
10%
Actual Data

Cases (fraction of the population)

Sensitivity w. r. t. Œ≤(t): Currently infected

0.0008

c

50%
40%
30%
20%
10%

0.000175
0.000150
0.000125
0.000100
0.000075
0.000050
0.000025
0.000000

0

200

400
Time (days)

600

Figure 11. Sensitivity of Œ≤ (t) with 50%, 40%, 30%, 20% and 10% reduction from current contact rate (India). Note that not
all panels are in the same scale.

With,
Ô£´
0 Œ≤0
Ô£¨0 0
Ô£¨
F =Ô£¨
Ô£¨0 0
Ô£≠0 0
0 0

Œ∫Œ≤0
0
0
0
0

œâŒ≤0
0
0
0
0

Ô£∂
œÅŒ≤0
0 Ô£∑
Ô£∑
0 Ô£∑
Ô£∑
0 Ô£∏
0

(19)

Similarly, we have
DV (X0 ) =
Ô£´

œÉ
Ô£¨ ‚àíŒ±œÉ
Ô£¨
Ô£¨‚àí (1 ‚àí Œ±) œÉ
Ô£¨
Ô£¨
0
Ô£¨
Ô£¨
0
Ô£¨
Ô£¨
0
Ô£¨
Ô£¨
0
Ô£¨
Ô£≠
0
0

0
0
0
0
0
(Œ∑ + Œ∏ + Œª )
‚àíŒΩ
0
0
0
0
(Œµ0 + ŒΩ + Œ≥)
0
0
0
0
‚àíŒµ0
(œï + ¬µ)
0
0
‚àíŒ∏
0
‚àíœï
(œÑ + œà)
0
‚àíŒª
0
0
‚àíœÑ
(Œ¥ + Œ∂ )
0
0
0
0
‚àíŒ¥
‚àíŒ∑
‚àíŒ≥
‚àí¬µ
‚àíœà
‚àíŒ∂
Œ≤0
Œ∫Œ≤0
œâŒ≤0
œÅŒ≤0
0

0
0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0
0

Ô£∂
0
0Ô£∑
Ô£∑
0Ô£∑
Ô£∑

0Ô£∑
Ô£∑
V
Ô£∑
0Ô£∑ =
J
3
0Ô£∑
Ô£∑
Ô£∑
0Ô£∑
0Ô£∏
0

0
J4



(20)

13/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

b

0.0008

0.0006

0.0004

0.0002

0

100

200
300
Time (days)

0.006

0.004

0.002

0.000

400

0

100

200
300
Time (days)

Sensitivity w. r. t. (t): Deaths

0.00015

0.00010

0.00005

0

100

Sensitivity w. r. t. (t): Cumulative Infected
Cases (fraction of the population)

0.00020

200
300
Time (days)

400

+20%
+40%
+60%
+80%
Double

0.012
0.010
0.008
0.006
0.004
0.002
0.000

0.010
0.008
0.006
0.004
0.002
0

100

200
300
Time (days)

400

f

0.014

+20%
+40%
+60%
+80%
Double

+20%
+40%
+60%
+80%
Double

0.012

0.000

400

e

0.00025
Cases (fraction of the population)

0.014

+20%
+40%
+60%
+80%
Double

0.008

d

0.00000

Sensitivity w. r. t. (t): Cumulative Recovered

0.010

0

100

200
300
Time (days)

400

Sensitivity w. r. t. (t): Critical

0.00025
Cases (fraction of the population)

0.0000

Sensitivity w. r. t. (t): Detected and Recovered
Cases (fraction of the population)

Cases (fraction of the population)

+20%
+40%
+60%
+80%
Double

Cases (fraction of the population)

Sensitivity w. r. t. (t): Currently infected

0.0010

c

+20%
+40%
+60%
+80%
Double

0.00020

0.00015

0.00010

0.00005

0.00000

0

100

200
300
Time (days)

400

Figure 12. Sensitivity of Œµ(t) with changed rate of testing by 1.2, 1.4, 1.6, 1.8 and 2 times the current rate (India). Note that
not all panels are in the same scale.
With,
Ô£´

œÉ
Ô£¨ ‚àíŒ±œÉ
Ô£¨
V =Ô£¨
Ô£¨‚àí (1 ‚àí Œ±) œÉ
Ô£≠
0
0

Ô£∂
0
0
0
0
(Œ∑ + Œ∏ + Œª )
‚àíŒΩ
0
0 Ô£∑
Ô£∑
0
(Œµ0 + ŒΩ + Œ≥)
0
0 Ô£∑
Ô£∑
0
‚àíŒµ0
(œï + ¬µ)
0 Ô£∏
‚àíŒ∏
0
‚àíœï
(œÑ + œà)

(21)

and,
1
œÉ
Œ±ŒΩ‚àíŒ±r
Ô£¨
‚àí r1 r33 ‚àíŒΩ
Ô£¨
Ô£¨
‚àí rŒ±3 + r13
V ‚àí1 = Ô£¨
Ô£¨
‚àí Œ±Œµ‚àíŒµ
Ô£≠
r3 r4
3 r4 Œ∏ ‚àíŒµr1 œï‚àíŒΩr4 Œ∏
‚àí Œ±Œµr1 œï+Œ±ŒΩr4 Œ∏r‚àíŒ±r
1 r2 r3 r4

Ô£´

0

0

1
r1

ŒΩ
r1 r3
1
r3
Œµ
r3 r4
Œµr1 œï+ŒΩr4 Œ∏
r1 r2 r3 r4

0
0
Œ∏
r1 r2

0
0
0
1
r4
œï
r2 r4

Ô£∂
0
0Ô£∑
Ô£∑
0Ô£∑
Ô£∑
Ô£∑
0Ô£∏

(22)

1
r2

Defining œÅ(A) = max {|Œª1 |, . . . , |Œªn |} as the spectral radius of an n √ó n matrix A, with eigenvalues Œª1 . . . Œªn , and |Àô| denoting
absolute values. According to24 , basic reproduction number R0 associated to the system can be computed as R0 = œÅ(FV ‚àí1 ).
Hence, based on the discussion above, for the baseline model we have,






Œ± ŒΩ (1 ‚àí Œ±)
1‚àíŒ±
Œµ0 (1 ‚àí Œ±)
R0 = Œ≤0
+
+ Œ∫Œ≤0
+ œâŒ≤0
r1
r1 r3
r3
r3 r4


(23)
Œ±Œ∏
(1 ‚àí Œ±) Œµ0 œï (1 ‚àí Œ±) ŒΩŒ∏
+œÅŒ≤0
+
+
r1 r2
r2 r3 r4
r1 r2 r3
14/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

b

0.0015

0.0010

0.0005

0.0000

0

200

400
Time (days)

600

0.015

0.010

0.005

0.000

0

200

400
Time (days)

0.05

250 days
200 days
150 days
100 days
50 days

0.0020

0.0015

0.0010

0.0005

0

200

400
Time (days)

600

0.02

0.01

0

200

400
Time (days)

600

Sensitivity w. r. t. œá: Currently Critical

0.05

250 days
200 days
150 days
100 days
50 days

0.04

0.03

0.02

0.01

0.00

0.03

f

Sensitivity w. r. t. œá: Cumulative Infected
Cases (fraction of the population)

Sensitivity w. r. t. œá: Cumulative Deaths

250 days
200 days
150 days
100 days
50 days

0.04

0.00

600

e

0.0025
Cases (fraction of the population)

250 days
200 days
150 days
100 days
50 days

0.020

d

0.0000

Sensitivity w. r. t. œá: Cumulative Recovered

0.025

Cases (fraction of the population)

0.0020

Sensitivity w. r. t. œá: Cumulative Detected and Recovered

0

200

400
Time (days)

0.0025
Cases (fraction of the population)

Cases (fraction of the population)

250 days
200 days
150 days
100 days
50 days

Cases (fraction of the population)

Sensitivity w. r. t. œá: Currently infected

0.0025

c

600

250 days
200 days
150 days
100 days
50 days

0.0020

0.0015

0.0010

0.0005

0.0000

0

200

400
Time (days)

600

Figure 13. Sensitivity of œá(t) with loss of acquired immunity over time by 250, 200, 150, 100 and 50 days (India). Note that
not all panels are in the same scale.
where, r1 = (Œ∑ + Œ∏ + Œª ), r2 = (œÑ + œà), r3 = (Œµ0 + ŒΩ + Œ≥), and r4 = (œï + ¬µ). When the epidemic is over, we will have the
condition that EÃÑ = I¬Ø = AÃÑ = QÃÑ = HÃÑ = CÃÑ = 0, DÃÑ ‚â• 0, RÃÑ ‚â• 0, SÃÑ ‚â• 0, with DÃÑ + RÃÑ + SÃÑ = 1. That is, only the susceptible, the recovered
and the deceased individuals are eventually present.
Proposition 1. The system of equation with susceptible population SÃÑ is asymptotically stable if and only if
SÃÑ ‚â§ SÃÑ‚àó =

1
R0

Proof. The dynamical system matrix of the linearized system near a DFE is given by:
Ô£´
Ô£∂
œâŒ≤0 SÃÑ
œÅŒ≤0 SÃÑ
0
0 0 0
‚àíœÉ
Œ≤0 SÃÑ
Œ∫Œ≤0 SÃÑ
Ô£¨ Œ±œÉ
‚àír1
ŒΩ
0
0
0
0 0 0Ô£∑
Ô£¨
Ô£∑
Ô£¨(1 ‚àí Œ±) œÉ
0
‚àír3
0
0
0
0 0 0Ô£∑
Ô£¨
Ô£∑
Ô£¨
0
0
Œµ0
‚àír4
0
0
0 0 0Ô£∑
Ô£¨
Ô£∑
0
Œ∏
0
œï
‚àír2
0
0 0 0Ô£∑
M=Ô£¨
Ô£¨
Ô£∑
Ô£¨
0
Œª
0
0
œÑ
‚àír5 0 0 0Ô£∑
Ô£¨
Ô£∑
Ô£¨
0
0
0
0
0
Œ¥
0 0 0Ô£∑
Ô£¨
Ô£∑
Ô£≠
0
Œ∑
Œ≥
¬µ
œà
Œ∂
0 0 0Ô£∏
0
‚àíŒ≤0 SÃÑ ‚àíŒ∫Œ≤0 SÃÑ ‚àíœâŒ≤0 SÃÑ ‚àíœÅŒ≤0 SÃÑ
0
0 0 0

(24)

(25)

Where r1 = (Œ∑ + Œ∏ + Œª ), r2 = (œÑ + œà), r3 = (Œµ0 + ŒΩ + Œ≥), r4 = (œï + ¬µ). and r5 = (Œ¥ + Œ∂ ). Using det(sI ‚àí M) = 0, we have
the characteristic polynomial of M having following form: s3 (r5 + s) p(s). Hence, the matrix has three null eigenvalues, one
eigenvalue of ‚àí (Œ¥ + Œ∂ ), and five eigenvalues that are roots of the polynomial p(s), where,
p(s) = D(s) ‚àí SÃÑN(s)

(26)
15/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

b

0.0015

0.0010

0.0005

0.0000

0

200

400
Time (days)

600

0.015

0.010

0.005

0.000

0

200

400
Time (days)

0.05

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

0.0020

0.0015

0.0010

0.0005

0

200

400
Time (days)

600

0.02

0.01

0

200

400
Time (days)

600

Sensitivity w. r. t. œÜ: Currently Critical

0.05

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

0.04

0.03

0.02

0.01

0.00

0.03

f

Sensitivity w. r. t. œÜ: Cumulative Infected
Cases (fraction of the population)

Sensitivity w. r. t. œÜ: Cumulative Deaths

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

0.04

0.00

600

e

0.0025
Cases (fraction of the population)

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

0.020

d

0.0000

Sensitivity w. r. t. œÜ: Cumulative Recovered

0.025

Cases (fraction of the population)

0.0020

Sensitivity w. r. t. œÜ: Cumulative Detected and Recovered

0

200

400
Time (days)

600

0.0025
Cases (fraction of the population)

Cases (fraction of the population)

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

Cases (fraction of the population)

Sensitivity w. r. t. œÜ: Currently infected

0.0025

c

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

0.0020

0.0015

0.0010

0.0005

0.0000

0

200

400
Time (days)

600

Figure 14. Sensitivity of vaccine efficiency parameter (1 ‚àí œÜ ), where œÜ = 0 represents vaccine that offers 100% protection
against infection, and Œæmax = 0.3, i.e. maximum of 30% population is administered with vaccine. œÜ is varied from 1.0 (No
vaccination), 0.5 (50% efficient), 0.25 (75% efficient), 0.125(87.5% efficient), and 0.0625 (93.75% efficient) (India)
with,
D(s) =
s5 + s4 (r1 + r2 + r3 + r4 + œÉ ) +
s3 (r1 r2 + r1 r3 + r1 r4 + r1 œÉ + r2 r3 + r2 r4 + r2 œÉ + r3 r4 + r3 œÉ + r4 œÉ ) +
s2 (r1 r2 r3 + r1 r2 r4 + r1 r2 œÉ + r1 r3 r4 + r1 r3 œÉ + r1 r4 œÉ + r2 r3 r4 +
r2 r3 œÉ + r2 r4 œÉ + r3 r4 œÉ )+
s (r1 r2 r3 r4 + r1 r2 r3 œÉ + r1 r2 r4 œÉ + r1 r3 r4 œÉ + r2 r3 r4 œÉ ) +
r1 r2 r3 r4 œÉ

(27)

and,
N(s) =
s3 Œ≤0 œÉ (1 ‚àí Œ±) Œ∫ + s3 Œ≤0 œÉ Œ±

s2 Œ≤0 œÉ (1 ‚àí Œ±) (Œµ0 œâ + ŒΩ + Œ∫ (r1 + r2 + r4 )) + s2 Œ≤0 œÉ Œ± (œÅŒ∏ + (r2 + r3 + r4 )) +
sŒ≤0 œÉ (1 ‚àí Œ±)(Œµ(œâr1 + œâr2 + œÅœï) + Œ∫(r1 r2 + r1 r4 + r2 r4 ) + ŒΩ(r2 + r4 + œÅŒ∏ ))+
sŒ≤0 œÉ Œ±(r2 r3 + r2 r4 + r3 r4 + r3 œÅŒ∏ + r4 œÅŒ∏ ) + œÉ r1 r2 r3 r4 R0

(28)

Defining G(s) = N(s)/D(s), and noting that the system is positive, and hence H‚àû norm of G(s) is equal to the static gain
G(0) = N(0)/D(0) = R0 . To have the real part of every root of the polynomial to be zero or negative (Hurwitz), we should
16/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

b

0.0020

0.0015

0.0010

0.0005

0

200

400
Time (days)

0.015

0.010

0.005

d
Sensitivity w. r. t. œÜ: Cumulative Deaths
No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

200

400
Time (days)

0.0020

0.0015

0.0010

0.0005

0

200

400
Time (days)

0.03

0.02

0.01

0

200

400
Time (days)

600

f
Sensitivity w. r. t. œÜ: Currently Critical

0.05

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

0.04

0.03

0.02

0.01

0.00

600

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

0.04

0.00

600

Sensitivity w. r. t. œÜ: Cumulative Infected
Cases (fraction of the population)

Cases (fraction of the population)

0

0.05

e

0.0025

0.0000

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

0.020

0.000

600

Sensitivity w. r. t. œÜ: Cumulative Recovered

0.025

0

200

400
Time (days)

600

0.0025
Cases (fraction of the population)

0.0000

Sensitivity w. r. t. œÜ: Cumulative Detected and Recovered
Cases (fraction of the population)

Cases (fraction of the population)

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

Cases (fraction of the population)

Sensitivity w. r. t. œÜ: Currently infected

0.0025

c

No vaccination
50% effective
75% effective
87.5% effective
93.75% effective

0.0020

0.0015

0.0010

0.0005

0.0000

0

200

400
Time (days)

600

Figure 15. Sensitivity of vaccine efficiency parameter (1 ‚àí œÜ ), where œÜ = 0 represents vaccine that offers 100% protection
against infection, and Œæmax = 0.7, i.e. maximum of 70% population is administered with vaccine. œÜ is varied from 1.0 (No
vaccination), 0.5 (50% efficient), 0.25 (75% efficient), 0.125(87.5% efficient), and 0.0625 (93.75% efficient) (India)
have SÃÑ‚àó = 1/G(0) = 1/R0 . Note that the stability of the equilibrium occurs for SÃÑR0 < 1. Since in the beginning of an epidemic
we have SÃÑ very close to 1, it should be noted that R0 < 1 is required to have small effect and stability.
Fitting of the model for the COVID-19 outbreak: Italy and India

We consider three scenarios to fit and estimate parameters for our model. First, for Italy, where the epidemic was controlled and
currently have a resurgence with increasing number of cases. Second, for India, which is observing significant number of cases
in recent times. Third, for Victoria, Australia, where a second reemergence is controlled with strict intervention.
For Italy, we use data from the official source (the Department of Civil Protection - Presidency of the Council of Ministers)
about the evolution of the epidemic in Italy from 2020-02-24 to 2020-08-27. We convert this data to fraction of population
by taking total population data from The World Bank Group (about 60297396, in 2019). The estimated parameter values
are based on the data about the number of currently infected individuals that can be observed and roughly corresponding
to (Q(t) + H(t) +C(t)), and the number of recovered individuals that can be observed and roughly corresponding to
Rt
(¬µQ(s)
+ œàH(s) + Œ∂C(s)) ds. To avoid the pitfalls described by authors in25 , we do not fit the model to cumulative number
0
of cases or cumulative number of deaths - however, we present them for comparison.
The ordinary differential equation (ODE) system was solved using LSODA26, 27 . We use lmfit python package28 for
non-linear least-squares and minimize of the sum of the squares of the errors using trust region reflective method and obtaining
goodness of fit measure of œá 2 = 5.3331e‚àí07 for Italy. Confidence interval for the fit is shown in Figure 18a. The problem to
minimize error is shown in following equation for fitting parameter set p:
m

pÃÇ ‚àà arg min S(p) = arg min ‚àë [yi ‚àí fi (xi , p)]2
p

p

(29)

i=1

where yi are observations and fi is the model output.
17/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

b
Currently Infected: Model vs. Data

0.004

0.003

0.002

0.001

0.000

0

25

50

75

100
Time (days)

125

150

0.003

0.002

0.001

0

25

50

75

100
Time (days)

125

150

175

150

175

d
Infected, Life-Threatening Symptoms: Model vs. Data

0.004

0.003

0.002

0.001

0.000

0

25

50

75

100
Time (days)

125

150

0.004

0.003

0.002

0.001

0.000

175

e

Deaths: Model vs. Data

0.005
Cases (fraction of the population)

0.005
Cases (fraction of the population)

0.004

0.000

175

c

0

25

50

75

100
Time (days)

125

f
Cumulative Cases: Model vs. Data

0.004

0.003

0.002

0.001

0.000

0

25

50

75

100
Time (days)

125

150

Infected, Symptoms: Model vs. Data

0.005
Cases (fraction of the population)

0.005
Cases (fraction of the population)

Recovered: Model vs. Data

0.005
Cases (fraction of the population)

Cases (fraction of the population)

0.005

175

0.004

0.003

0.002

0.001

0.000

0

25

50

75

100
Time (days)

125

150

175

Figure 16. Model simulation compared to real data (Victoria, Australia) - Comparison between the official data (histogram)
and the results with our model. DescriptionR of panels: (a): Number of currently active cases, (Q(t) + H(t) +C(t)), (b):
number of reported recovered individuals. 0t (¬µQ(s) + œàH(s) + Œ∂C(s)) ds, (c): number of reported infected with
life-threatening symptoms, admitted
to ICU, C(t), (d): Number of deceased individuals D(t), (e): Cumulative number of cases,
R
Q(t) + H(t) +C(t) + D(t) + 0t (¬µQ(s) + œàH(s) + Œ∂C(s)) ds (f): number of reported infected with symptoms, who are
hospitalized. H(t)

For India (population 1366417754, in 2019), we use data from Johns Hopkins University Center for Systems Science and
Engineering (JHU CSSE). We use data from 2020-03-02 to 2020-09-16. The estimated parameter values are based on the data
about the number of currently infected individuals that can be observed and roughly corresponding to (Q(t) + H(t) +C(t)). In
this case we obtain a goodness of fit measure of œá 2 = 4.4811e‚àí08 and confidence interval for the fit is shown in Figure 18b.
Parameters Œ≤0 , Œ≤min , Œ≤new ,t0 ,t1 , r, u, Œµ0 , Œµmax ,t2 and s have all been estimated from fitting the model to data. It is important to
18/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

b
Short-term evolution: actual vs diagnosed cases of infection

0.004

0.003

0.002

0.001

0.000

0

25

50

75

100
125
Time (days)

150

175

0.003

0.002

0.001

0

50

100

150

200
250
Time (days)

300

350

400

350

400

d
Short-term evolution: Infected sub-population

0.0010

0.0008

0.0006

0.0004

0.0002

0

25

50

75

100
125
Time (days)

150

175

Long-term evolution: Infected sub-population

0.0010

Symptomatic, Undected
Symptomatic, Diagnosed
Asymptomatic, Undected
Isolated
Critical

Cases (fraction of the population)

Cases (fraction of the population)

Recovered
Deaths
Diagnosed recovered
Cumulative infected
Current total infected

0.004

0.000

200

c

0.0000

Long-term evolution: actual vs diagnosed cases of infection

0.005

Recovered
Deaths
Diagnosed recovered
Cumulative infected
Current total infected

Cases (fraction of the population)

Cases (fraction of the population)

0.005

200

Symptomatic, Undected
Symptomatic, Diagnosed
Asymptomatic, Undected
Isolated
Critical

0.0008

0.0006

0.0004

0.0002

0.0000

0

50

100

150

200
250
Time (days)

300

Figure 17. Model simulation compared to real data (Victoria, Australia) - Epidemic evolution predicted by the model based
on the available data. Description of panels: (a, c): The short-term epidemic evolution obtained by reproducing the data trend
with the model, (b, d): Long term epidemic evolution over 350 days. Plots refers to all cases of infection, both diagnosed and
non-diagnosed, predicted by the model, although non-diagnosed cases are of course not counted in the data. Note that not all
panels are in the same scale.

note that contact rat Œ≤ (t) and testing rate Œµ(t) has been modeled as time variant functions.
For the state of Victoria, Australia, we use data from Covid19data.com.au, which is independent and voluntarily-run. We
use data from 2020-02-27 to 2020-09-09. The estimated parameter values are based on the data about the number of currently
infected individuals, and we obtain a goodness of fit measure of œá 2 = 1.6701e‚àí06 .
Extending the baseline model
In this section we consider various extension of the model and parameters.
Scenario: Confinement

First extension is to model confinement - where a large proportion of susceptible population is placed under restricted movement,
and thereby reducing the probability of contact. Such restriction has been modeled by introducing another compartment L.
Individuals from S move to L at rate u(t). In many countries, confinement was spread over several weeks followed by a period
of de-confinement. We model de-confinement by individuals moving from L to S at rate p(t). In specific we modify equation
19/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Param
Œ≤
Œ∫
œâ
œÅ
œÉ
Œ±

Description
infectious contact rate
infectiousness factor asymptomatic
infectiousness factor quarantined
infectiousness factor isolated
transition rate exposed to infectious
fraction of infections that become symptomatic
transition rate asymptomatic to symptomatic
detection rate asymptomatic
rate of quarantined to isolation
rate of detection of symptomatic
rate of developing life-threatening symptoms
in isolation
rate of developing life-threatening symptoms
for symptomatic
recovery rate of asymptomatic
recovery rate of symptomatic
recovery rate of quarantined
recovery rate of isolated
recovery rate of critical
mortality rate

ŒΩ
Œµ
œï
Œ∏
œÑ
Œª
Œ≥
Œ∑
¬µ
œà
Œ∂
Œ¥

Possible Range
0.5-1.5 day‚àí117, 18
0.4-0.618, 19
0.005-0.01149
0.005-0.01149
1/14-1/3 day‚àí118, 20
0.15-0.718, 19, 21

Default
1.14 day‚àí1
0.5
0.0114
0.0114
1/5.2 day‚àí1
0.3

0.025-0.1259
0.1719
0.025-0.1259
0.3719
0.0279

0.125
0.171
0.125
0.371
0.027

0.0179

0.017

0.0349
0.0179
0.0349
0.0179
0.0179, 21
0.01-0.059, 19, 22

0.034
0.017
0.034
0.017
0.017
0.01

Table 1. Baseline parameters, brief description, possible ranges based on modeling and clinical studies, and default value
chosen for this study. Note that these parameters were estimated to fit the model to real data

95% confidence bands for the model (Italy)

95% confidence bands for the model (India)

data
best-fit
2-œÉ uncertainty band

0.003

0.002

0.0008
Cases (fraction of the population)

Cases (fraction of the population)

data
best-fit
2-œÉ uncertainty band

0.0010

0.001

0.000

0.0006

0.0004

‚àí0.001
0.0002
‚àí0.002

0.0000
‚àí0.003

0

25

50

75
100
Time (days)

125

150

175

(a) Fitting model to data, Italy

0

25

50

75
100
Time (days)

125

150

175

(b) Fitting model to data, India

Figure 18. Parameter estimation and fitting model to actual data for Italy and India using lmfit. The plot show actual data,
best fit by minimizing sum of the squares of the errors, and 2-œÉ uncertainty band
(9) as follows
dS
S
= p(t)L ‚àí Œ≤ (t) (I + Œ∫A + œâQ + œÅH) ‚àí u(t)S,
dt
N

(30)
20/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

We also add following dynamics to the baseline model
dL
= u(t)S ‚àí p(t)L,
dt

(31)

Thus, equations (1-8), equation (30), and (31) along with equation (10), defines the confinement - de-confinement scenario. A
few remarks are in place for the time dependent functions u(t) and p(t).
Scenario: Loss of immunity

To consider the possibility of loosing acquired immunity over time and having a reinfection, we modify equation (9) and add a
term +œáR and modify equation (8) by adding term ‚àíœáR to obtain:
dS
S
= ‚àíŒ≤ (t) (I + Œ∫A + œâQ + œÅH) + œáR,
dt
N

(32)

dR
= (Œ∑I + Œ≥A + ¬µQ + œàH + Œ∂C) ‚àí œáR,
dt

(33)

Scenario: Mass Vaccination

In this scenario, we assume that the susceptible individuals are vaccinated at rate Œæ (t). Initially Œæ (t) can be small and as more
vaccines are produced at a larger scale, the waiting time to receive vaccine reduces (see equation (34)).
(
Œæ0
t < t0
Œæ (t) =
(34)
‚àís(t‚àít
)
0
Œæmax ‚àí (Œæmax ‚àí Œæ0 )e
t > t0
We also assume a vaccine efficiency parameter, and assume that vaccine does not confer immunity to all vaccine recipients,
and hence a vaccinated individuals may become infected but at a lower rate than un-vaccinated. Hence, by (1 ‚àí œÜ ) we denote
vaccine efficiency. Thus, effective contact rate is multiplied by a scaling factor of œÜ : 0 ‚â§ œÜ ‚â§ 1, where œÜ = 0 represents vaccine
that offers 100% protection against infection.
The vaccinated individuals will be denoted with compartment V . With that, the augmented model can be represented with
following system of equations, where we replace equation (1) with (35), equation (9) with (37), remaining equations (2)-(8)
remains same and we add equations (36), and ((38):
dE
S
V
= Œ≤ (t) (I + Œ∫A + œâQ + œÅH) + œÜ Œ≤ (t) (I + Œ∫A + œâQ + œÅH) ‚àí œÉ E,
dt
N
N

(35)

dV
V
= Œæ (t)S ‚àí œÜ Œ≤ (t) (I + Œ∫A + œâQ + œÅH) ,
dt
N

(36)

dS
S
= ‚àíŒ≤ (t) (I + Œ∫A + œâQ + œÅH) ‚àí Œæ (t)S,
dt
N

(37)

where,
N(t) = S(t) + E(t) + A(t) + I(t) + Q(t) + H(t) + R(t) + D(t) +V (t),

(38)

is the total population.

Authors‚Äô contributions
S. K. G.: Conceptualization, Data Collection, Software, Visualization, Writing - Original Draft, Writing - Review and Editing.
S. G.: Conceptualization, Writing - Original Draft, Writing - Review and Editing. All authors reviewed the manuscript.

Data availability
All of the data are publicly available and were extracted from https://github.com/pcm-dpc/COVID-19, and from
https://github.com/CSSEGISandData/COVID-19.
21/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Code availability
Python codes were used for model implementation. All source codes can be accessed from https://github.com/
subhaskghosh/model_covid_19

Competing Interests statement
The authors have no competing interests.

References
1. Liu, Y., Gayle, A. A., Wilder-Smith, A. & Rockl√∂v, J. The reproductive number of covid-19 is higher compared to sars
coronavirus. J. Travel. Medicine 27, DOI: 10.1093/jtm/taaa021 (2020).
2. Hu, Z. et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in
Nanjing, China. Sci China Life Sci 63, 706‚Äì711 (2020).
3. Nishiura, H. et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int. J. Infect. Dis. 94,
154‚Äì155 (2020).
4. Bai, Y. et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA 323, 1406‚Äì1407 (2020).
5. Mizumoto, K., Kagaya, K., Zarebski, A. & Chowell, G. Estimating the asymptomatic proportion of coronavirus disease
2019 (covid-19) cases on board the diamond princess cruise ship, yokohama, japan, 2020. Eurosurveillance 25, DOI:
https://doi.org/10.2807/1560-7917.ES.2020.25.10.2000180 (2020).
6. Long, Q.-X. et al. Clinical and immunological assessment of asymptomatic sars-cov-2 infections. Nat. Medicine 26,
1200‚Äì1204, DOI: 10.1038/s41591-020-0965-6 (2020).
7. Diekmann, O. & Heesterbeek, J. Mathematical epidemiology of infectious diseases: model building, analysis and
interpretation. Wiley series in mathematical and computational biology (John Wiley and Sons, United States, 2000).
8. Gumel, A. B. et al. Modelling strategies for controlling sars outbreaks. Proc. Royal Soc. London. Ser. B: Biol. Sci. 271,
2223‚Äì2232, DOI: 10.1098/rspb.2004.2800 (2004). https://royalsocietypublishing.org/doi/pdf/10.1098/rspb.2004.2800.
9. Giordano, G. et al. Modelling the covid-19 epidemic and implementation of population-wide interventions in italy. Nat.
Medicine 26, 855‚Äì860, DOI: 10.1038/s41591-020-0883-7 (2020).
10. Peng, L., Yang, W., Zhang, D., Zhuge, C. & Hong, L. Epidemic analysis of covid-19 in china by dynamical modeling.
medRxiv DOI: 10.1101/2020.02.16.20023465 (2020). https://www.medrxiv.org/content/early/2020/02/18/2020.02.16.
20023465.full.pdf.
11. Tang, B. et al. An updated estimation of the risk of transmission of the novel coronavirus (2019-ncov). Infect. Dis. Model.
5, 248 ‚Äì 255, DOI: https://doi.org/10.1016/j.idm.2020.02.001 (2020).
12. Eikenberry, S. E. et al. To mask or not to mask: Modeling the potential for face mask use by the general public to curtail
the covid-19 pandemic. Infect. Dis. Model. 5, 293 ‚Äì 308, DOI: https://doi.org/10.1016/j.idm.2020.04.001 (2020).
13. Chhabra, M. & Agrawal, T. A comprehensive analysis of r0 with different lockdown phase during covid-19 in india.
medRxiv DOI: 10.1101/2020.07.10.20150631 (2020). https://www.medrxiv.org/content/early/2020/07/11/2020.07.10.
20150631.full.pdf.
14. Marimuthu, S. et al. Modelling of reproduction number for covid-19 in india and high incidence states. Clin. Epidemiol.
Glob. Heal. DOI: https://doi.org/10.1016/j.cegh.2020.06.012 (2020).
15. Saul, A. et al. Victoria‚Äôs response to a resurgence of covid-19 has averted 9,000-37,000 cases in july 2020. Med J Aust
(2020).
16. Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with covid-19 in wuhan, china: a retrospective
cohort study. The Lancet 395, 1054‚Äì1062, DOI: 10.1016/S0140-6736(20)30566-3 (2020).
17. Shen, M., Peng, Z., Xiao, Y. & Zhang, L. Modelling the epidemic trend of the 2019 novel coronavirus outbreak in china.
bioRxiv DOI: 10.1101/2020.01.23.916726 (2020).
18. Li, R. et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (sars-cov-2). Science
368, 489‚Äì493, DOI: 10.1126/science.abb3221 (2020). https://science.sciencemag.org/content/368/6490/489.full.pdf.
19. Ferguson, N. et al. Report 9: Impact of non-pharmaceutical interventions (npis) to reduce covid-19 mortality and healthcare
demand. DOI: 10.25561/77482 (2020).
22/23

medRxiv preprint doi: https://doi.org/10.1101/2020.09.19.20198051; this version posted September 22, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

20. Lauer, S. A. et al. The incubation period of 2019-ncov from publicly reported confirmed cases: estimation and application.
medRxiv DOI: 10.1101/2020.02.02.20020016 (2020).
21. Moriarty, L. F. et al. Public health responses to COVID-19 outbreaks on cruise ships ‚Äî worldwide, february‚Äìmarch 2020.
MMWR. Morb. Mortal. Wkly. Rep. 69, 347‚Äì352, DOI: 10.15585/mmwr.mm6912e3 (2020).
22. Modi, C., Boehm, V., Ferraro, S., Stein, G. & Seljak, U. How deadly is covid-19? a rigorous analysis of excess mortality
and age-dependent fatality rates in italy. medRxiv DOI: 10.1101/2020.04.15.20067074 (2020). https://www.medrxiv.org/
content/early/2020/05/14/2020.04.15.20067074.full.pdf.
23. Diekmann, O., Heesterbeek, J. A. P. & Metz, J. A. J. On the definition and the computation of the basic reproduction ratio
r0 in models for infectious diseases in heterogeneous populations. J. Math. Biol. 28, 365‚Äì382, DOI: 10.1007/BF00178324
(1990).
24. van den Driessche, P. & Watmough, J. Reproduction numbers and sub-threshold endemic equilibria for compartmental
models of disease transmission. Math. Biosci. 180, 29 ‚Äì 48, DOI: https://doi.org/10.1016/S0025-5564(02)00108-6 (2002).
25. King, A. A., Domenech de Cell√®s, M., Magpantay, F. M. G. & Rohani, P. Avoidable errors in the modelling of
outbreaks of emerging pathogens, with special reference to ebola. Proc. Royal Soc. B: Biol. Sci. 282, 20150347, DOI:
10.1098/rspb.2015.0347 (2015). https://royalsocietypublishing.org/doi/pdf/10.1098/rspb.2015.0347.
26. Petzold, L. Automatic selection of methods for solving stiff and nonstiff systems of ordinary differential equations. SIAM
J. on Sci. Stat. Comput. 4, 136‚Äì148, DOI: 10.1137/0904010 (1983). https://doi.org/10.1137/0904010.
27. Hindmarsh, A. C. & Petzold, L. R. Lsoda, ordinary differential equation solver for stiff or non-stiff system (Sep 2005).
MATHEMATICAL METHODS AND COMPUTING.
28. Newville, M., Stensitzki, T., Allen, D. B. & Ingargiola, A. Lmfit: Non-linear least-square minimization and curve-fitting
for python, DOI: 10.5281/ZENODO.11813 (2014).

23/23

